Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I)

Journal of Emergency Medicine

Volumn 18, Issue 1, 2000, Pages 109-119

  Edlich, Richard F ^a   Arnette, Jarrett A ^a   Williams, Freddie M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adult T cell leukemia; HTLV I associated myelopathy tropical spastic paraparesis; Human T cell lymphotrophic virus I; Lymphoma; Public health initiatives; Seroprevalence; Transmission

Indexed keywords

ASCORBIC ACID; AZATHIOPRINE; CALCITONIN; CYTOKINE; DANAZOL; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; PENTOSTATIN; PREDNISOLONE; VIRUS VACCINE;

HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HYPERCALCEMIA; IMMUNIZATION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SEROPREVALENCE; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; SYMPTOM; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0033957968     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(99)00173-0     Document Type: Article

References (118)

1. Gallo R.C., Thomson M.M. Introduction. Höllsberg P., Hafler D.A. Human T-Cell Lymphotrophic Virus Type I. 1996;1-10 John Wiley & Sons, New York.
2. Jarrett W.F., Martin W.B., Crighton G.W., Dalton R.G., Stewart M.F. Leukemia in the cat. Transmission experiments with leukemia (lymphosarcoma). Nature. 202:1964;566-567.
3. Hardy W.D. Jr, Hess A.W., Macewen E.G., et al. Biology of feline leukemia virus in the natural environment. Cancer Res. 36:1976;582-588.
4. Temin H.M., Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature. 226:1970;1211-1213.
5. Collins S.J., Gallo R.C., Gallagher R.E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 270:1977;347-349.
6. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 77:1980;7415-7419.
7. de Thé G., Gessain A., Gazzolo L., et al. Comparative seroepidemiology of HTLV-I and HTLV-II in the French West Indies and some African countries. Cancer Res. 45:1985;4633s-4636s.
8. Essex M., Mclanes M.F., Tachibana N., Francis D.P., Lee T.H. Seroepidemiology of human T-cell leukemia virus in relation to immunosuppression and the acquired immunodeficiency syndrome. Gallo R.C., Essex M., Gross L. Human T-Cell Leukemia/Lymphoma Virus. 1984;355-362 Cold Spring Harbor Laboratory, New York.
9. Hinuma Y., Komodo H., Chosa T., et al. Antibodies to adult T-cell leukemia-virus associated antigen (ATLA) in sera from patients with ATL and controls in Japan a nationwide seroepidemiologic study . Int J Cancer. 29:1982;631-635.
10. Manzari V., Gradilone A., Barillari G., et al. HTLV-I is endemic in southern Italy detection of the first infectious cluster in a white population . Int J Cancer. 36:1985;557-559.
11. Sugiyama H., Doi H., Yamaguchi K., Tsuji Y., Miyamoto T., Hino S. Significance of postnatal mother-to-child transmission of human T-lymphotropic virus type-I on the development of adult T-cell leukemia/lymphoma. J Med Virol. 20:1986;253-260.
12. Kaplan J.E., Khabbaz R.F. HTLV-I newest addition to blood donor screening . Am Fam Phys. 40:1989;189-195.
13. Robert-Guroff M., Weiss S.H., Giron J.A., et al. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA. 255:1986;3133-3137.
14. Khabbaz R.F., Darrow W.W., Lairmore M., et al. Prevalence of antibody to HTLV-I among 1415 female prostitutes in the United States. 1988;IVth International Conference on AIDS, Stockholm.
15. Minamoto G.Y., Gold J.W., Scheinberg D.A., et al. Infection with human T-cell leukemia virus type-I in patients with leukemia. N Engl J Med. 318:1988;219-222.
16. Kelen G.D., DiGiovanna T.A., Lofy L., et al. Human T-lymphotropic virus (HTLV-I-II) infection among patients in an inner-city emergency department. Ann Intern Med. 113:1990;368-372.
17. Williams A.E., Fang C.T., Slamon D.J., et al. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. Science. 240:1988;643-646.
18. Centers for Disease Control. Human T-lymphotropic virus type-I screening in volunteer blood donors - United States. MMWR 1990;39:915, 921-4.
19. Blayney D.W., Blattner W.A., Robert-Guroff M., et al. The human T-cell leukemia-lymphoma virus in the southeastern United States. JAMA. 250:1983;1048-1052.
20. de Thé G., Bomford R. An HTLV-I vaccine why, how, for whom? AIDS Res Hum Retroviruses. 9:1993;381-386.
21. Komuro A., Hayami M., Fujii H., Miyahara S., Hirayama M. Vertical transmission of adult T-cell leukemia virus. Lancet. 1:1983;240.
22. Hino S., Yamaguchi K., Katamine S., et al. Mother-to-child transmission of human T-cell leukemia virus type-I. Gann. 76:1985;474-480.
23. Kinoshita K., Hino S., Amagasaki T., et al. Demonstration of adult T-cell leukemia virus antigen in milk from three seropositive mothers. Gann. 75:1975;103-105.
24. Yamanouchi K., Kinoshita K., Moriuchi R., et al. Oral transmission of human T-cell leukemia virus type-I into a common marmoset as an experimental model for milk-borne transmission. Gann. 76:1985;481-487.
25. Osame M, Miyata K, Nagat Y, Sonoda S, et al. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. Int J Cancer 1991;49:673-7. The Mother-to-Child Transmission Study Group.
26. Ando Y., Nakano S., Saito K., et al. Transmission of adult T-cell leukemia retrovirus (HTLV-I) from carrier mother to child comparison of bottle- with breast-fed babies . Jpn J Cancer Res. 78:1987;322-324.
27. Kajiyama W., Kashiwagi S., Ikematsu H., Hayashi J., Nomura H., Okochi K. Intrafamilial transmission of adult T-cell leukemia virus. J Infect Dis. 154:1986;851-857.
28. Nakano S., Ando Y., Ichijo M., et al. Search for possible routes of vertical and horizontal transmission of adult T cell leukemia virus. Gann. 75:1984;1044-1045.
29. Murphy E.L., Figueroa J.P., Gibbs W.N., et al. Sexual transmission of human T-lymphotrophic virus type I (HTLV-I). Ann Intern Med. 111:1989;555-560.
30. Bartholomew C., Saxinger W.C., Clark J.W., et al. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA. 257:1987;2604-2608.
31. Okochi K., Sato H., Hinuma Y. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion seroconversions in recipients . Vox Sang. 46:1984;245-253.
32. Manns A., Wilks R.J., Murphy E.L., et al. A prospective study of transmission of HTLV-I and risk factors associated with seroconversion. Int J Cancer. 51:1992;886-891.
33. Osame M., Janssen R., Kubota H., et al. Nationwide survey of HTLV-I-associated myelopathy in Japan association with blood transfusion . Ann Neurol. 28:1990;50-56.
34. Gout O., Baulac M., Gessain A., et al. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med. 322:1990;383-388.
35. Chen Y.-C., Wang C.-H., Su I.-J., et al. Infection of human T cell leukemia virus Type I and development of human T cell leukemia/lymphoma in patients with hematologic neoplasms a possible linkage to blood transfusion . Blood. 74:1989;388-394.
36. Lee H., Swanson P., Shorty V.S., Zack J.A., Rosenblatt J.D., Chen I.S.Y. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science. 244:1989;471-475.
37. Kataoka R., Takehara N., Iwahar Y., Ohtsuhi Y., Hoshion D.H., Miyoshi I. Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits. Blood. 76:1990;1657-1661.
38. Amin RM, Jones B, Rubert M, et al. Risk of retroviral infection among retrovirology laboratory and health care workers. New Orleans: American Society of Microbiology 92nd General Meeting; 1992. Abstract.
39. Recommendations for prevention of HIV transmission in health-care settings. MMWR Morb Mortal Wkly Rep. 36:(2s):1987;3s-18s.
40. Tajima K. The 4th nationwide study of adult T-cell leukemia/lymphoma (ATLL) in Japan estimates of risk of ATLL and its geographical and clinical features. The T- and B-cell malignancy study group . Int J Cancer. 45:1990;237-243.
41. Gessain A., Yanagihara R., Franchini G., et al. Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. Proc Natl Acad Sci USA. 88:1991;7694-7698.
42. Murai K., Tachibana N., Shioiri S., et al. Suppression of delayed-type hypersensitivity to PPD and PHA in elderly HTLV-1 carriers. J Acquir Immune Defic Syndr. 3:1990;1006-1009.
43. Morgan O., Rodgers-Johnson P., Mora C., Char G. HTLV-I and polymyositis in Jamaica. Lancet. 2:1989;1184-1186.
44. Ijiehi S., Matsuda T., Maruyama I., et al. Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis. 49:1990;718-721.
45. Lagrenade L., Hanchard B., Fletcher V., Cranston B., Blattner W. Infective dermatitis of Jamaican children a marker for HTLV-I infection . Lancet. 336:1990;1345-1347.
46. Moehizuki M., Watanabe T., Yamaguchi K., et al. HTLV-I uveitis a distinct clinical entity caused by HTLV-I . Jpn J Cancer Res. 83:1992;236-239.
47. Bartholomew C., Blattner W., Cleghom P. Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad. Lancet. 2:1987;1469.
48. Page J.B., Lal S., Chitwood D.D., Klimas N.G., Smith P.C., Fletcher M.A. HTLV I/II seropositivity and death from AIDS among HIV-I seropositive intravenous drug users. Lancet. 335:1990;1439-1441.
49. Osame M., Igata A., Matsumoto M., Kohka M., Usuku K., Izumo S. HTLV-I- associated myelopathy (HAM), treatment trials, retrospective survey, and clinical and laboratory findings. Hematol Rev. 3:1990;271-284.
50. Osame M., Igata A., Usuku K., Rosales L., Matsumoto M. Mother-to-child transmission in HTLV-I- associated myelopathy. Lancet. 1:1987;106.
51. Osame M., Janssen R., Kubota H., et al. Nationwide survey of HTLV-associated myelopathy in Japan association with blood transfusion . Ann Neurol. 28:1990;51-56.
52. Osame M., Matsumoto M., Usuku K., et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotrophic virus type I and adult T-cell leukemia-like cells. Ann Neurol. 21:1987;117-122.
53. Grimaldi L.M., Roos R.P., Devare S.G., et al. HTLV-I-associated myelopathy oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody . Ann Neurol. 24:1988;727-731.
54. Saito T., Osame M., Usuku K., Izumo S., Matsumoto M., Igata A. Oligoclonal immunoglobulin bands and HTLV-I-associated myelopathy detection by agarose isoelectric focusing, transfer to cellulose nitrate membrane, and immunoperoxidase staining . Roman G., Vernant J.C., Osame M. HTLV-I and the Nervous System. 1989;315-318 Alan R Liss, New York.
55. Nomoto M., Utatsu Y., Soejima Y., Osame M. Neopterin in cerebrospinal fluid a useful marker for diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis . Neurology. 41:1991;457.
56. Imamura A., Kitagawa T., Ohi Y., Osame M. Clinical manifestation of human T-cell lymphotrophic virus type-I-associated myelopathy and vesicopathy. Urol Int. 46:1991;149-153.
57. Newton M., Cruickshank K., Miller D., et al. Antibody to human T-cell lymphotrophic virus type I in West Indian-born UK residents with spastic paraparesis. Lancet. 1:1987;415-416.
58. Kira J., Minato S., Itoyama Y., Goto I., Kato M., Hasuo K. Leukoencephalopathy in HTLV-I-associated myelopathy MRI and EEG data . J Neurol Sci. 87:1988;221-223.
59. Furukawa Y., Osame M., Une F. Magnetic resonance imaging abnormalities in HTLV-I-associated myelopathy (HAM). Roman G., Vernant J.C., Osame M. HTLV-I and the Nervous System. 1989;393-396 Alan R Liss, New York.
60. Tashiro K., Maruo Y., Shiokawa T., et al. MS-like features in patients with HTLV-I-associated myelopathy. Roman G., Vernant J.C., Osame M. HTLV-I and the Nervous System. 1989;209-212 Alan R Liss, New York.
61. Arimura K., Rosales R., Osame M., Igata M. Clinical electro-physiologic studies of HTLV-I-associated myelopathy. Arch Neurol. 44:1987;609-612.
62. Shibasaki H., Endo C., Kuroda Y., Kakigi R., Oda K., Komine S. Clinical picture of HTLV-I-associated myelopathy. J Neurol Sci. 87:1988;15-24.
63. Kakigi R., Shibasaki H., Kuroda Y., et al. Multimodal evoked potentials in HTLV-I-associated myelopathy. J Neurol Neurosurg Psychiatry. 51:1988;1094-1096.
64. Ludolf A.C., Hugon J., Roman G.C., Spencer P.S., Schoenberg B.S. A clinical neurophysiologic study of tropical spastic paraparesis. Muscle Nerve. 11:1988;392-397.
65. Cruickshank J.K., Rudge P., Dalgleish A.G., et al. Tropical spastic paraparesis and human T-cell lymphotrophic virus type 1 in the United Kingdom. Brain. 112:1989;1057-1090.
66. Castillo J.L., Cartier L., Araya F., Verdugo R., Mora C., Gibbs C. Evoked potential abnormalities in progressive spastic paraparesis associated to HTLV-I. Acta Neurol Scand. 83:1993;151-154.
67. Tomita I., Shibayama K., Matsuo H., Kinoshita I., Tsujihata M., Nagataki S. Central motor conduction time in patients with HTLV-I-associated myelopathy. Acta Neurol Scand. 79:1989;419-427.
68. Arimura Y., Arimura K., Osame M., Igata A. Neuro-ophthalmological abnormalities in HTLV-I-associated myelopathy. Neuro-ophthalmology. 7:1987;243-248.
69. Yonenga Y., Arimura K., Suehara M., Arimura Y., Osame M. Electroencephalographic abnormalities in HTLV-I-associated myelopathy. Arch Neuro. 46:1989;513-516.
70. Arimura K., Arimura Y., Yonega Y., Rosales R.L., Osame M. Clinical electrophysiologic findings in patients with HTLV-I-associated myelopathy (HAM). Roman G., Vernant J.C., Osame M. HTLV-I and the Nervous System. 1989;245-250 Alan R Liss, New York.
71. Bhigjee A.I., Kelbe C., Haraibhai H.C., et al. Myelopathy associated with human T-cell lymphotrophic virus type I (HTLV-I) in Natal, South Africa. A clinical and investigative study in 24 patients. Brain. 113:1990;1307-1320.
72. Arimura K. Electrophysiologic studies on the peripheral nervous system of HTLV-I-associated myelopathy. Acta Med Univ Kagoshima. 29:1987;7-11.
73. Arimura K., Arimura Y., Moritoyo H., et al. How helpful is thoracic paraspinal EMG in HAM/TSP? Muscle Nerve. 18:1995;248-250.
74. Vernant J.C., Maurs L., Gout O., et al. HTLV-I-associated tropical spastic paraparesis in Martinique a reappraisal . Ann Neurol. 23:((suppl)):1988;S133-S135/LAST-PAGE.
75. Osame M., Igata A., Matsumoto M. HTLV-I-associated myelopathy (HAM) revisited. Roman G., Vernant J.C., Osame M. HTLV-I and the Nervous System. 1989;Alan R Liss, New York.
76. Matsuo H., Nakamura T., Tsujihata M., et al. Plasmapheresis in treatment of human T-cell lymphotrophic virus type-I associated myelopathy. Lancet. 2:1988;1109-1113.
77. Matsuo H., Nakamura T., Shibayama K., Nagasato K., Tsujihata M., Nagataki S. Long-term follow-up of immunodilation in treatment of HTLV-I-associated myelopathy (HAM). Lancet. 1:1989;790.
78. Izumo S., Usuku K., Osame M., Arimura K., Igata A. Effect of α-interferon treatment of HTLV-I-associated myelopathy (HAM). Neurology. 39:(suppl):1988;242.
79. Harrington W., Sheremata W., Snodgrass S., Emerson S., Phillips S., Berger J. Tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) treatment with an anabolic steroid danazol . AIDS Res Hum Retroviruses. 7:1991;1031-1034.
80. Kataoka A., Imai H., Inayoshi S., Tsuda T. Intermittent high-dose vitamin C therapy in patients with HTLV-I-associated myelopathy. J Neurol Neurosurg Psychiatry. 56:1993;1213-1216.
81. Takatsuki K., Yamaguchi K., Matsuoka M. ATLL and HTLV-I related diseases. Takatsuki K. Adult T-cell Leukemia. 1994;1-27 Oxford University Press, Oxford.
82. Matutes E., Brito-Babapulle V., Catovsky D. Clinical, immunological, ultrastructural, and cytogenetic studies in black patients with adult T-cell leukemia/lymphoma. Miwa M., Sugano H., Sugimura T., Weiss A. Retroviruses in Human Lymphoma/Leukemia. 1985;59-70 Japan Scientific Societies Press, Tokyo.
83. Blattner W.A., Nomur A., Clark J.W., et al. Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii. Proc Natl Acad Sci USA. 83:1986;4895-4898.
84. Yamaguchi K., Matutes E., Catovsky D., Galton D.A., Nakada K., Takatsuki K. Strongyloides stercoralis as candidate co-factor for HTLV-I-induced leukaemogenesis. Lancet. 2:1987;94-95.
85. Yamamoto S., Hattori T., Asou N., et al. Absolute neutrophilia in adult T cell leukemia. Jpn J Cancer Res. 77:1986;858-861.
86. Vukelja S.J., Weiss R.B., Perry D.J., Longo D.L. Eosinophilia associated with adult T cell leukemia/lymphoma. Cancer. 62:1988;1527-1530.
87. Tsuda H., Sawada T., Sakata K.M., Takatsuki K. Possible mechanisms for the elevation of serum β2-microglobulin levels in adult T-cell leukemia. Int J Hematol. 55:1992;179-187.
88. Yasuda N., Lai P.K., Ip S.H., et al. Soluble IL-2 receptors in the sera of Japanese patients with adult T-cell leukemia mark activity of disease. Blood. 71:1988;1021-1026.
89. Yamaguchi K., Nishimura Y., Kiyokawa T., Takatsuki K. Elevated serum levels of soluble IL-2 receptors in HTLV-I-associated myelopathy. J Lab Clin Med. 114:1989;407-410.
90. Chosa T., Hattori T., Matsuoka M., Yamaguchi K., Yamamoto S., Takatsuki K. Analysis of anti-HTLV-I antibodies by strip radioimmunoassay - comparison with indirect immunofluorescence assay. Leuk Res. 10:1986;605-610.
91. Kiyokawa T., Yamaguchi K., Takeya M., et al. Hypercalcemia and osteoclast proliferation in adult T-cell leukemia. Cancer. 59:1987;1187-1191.
92. Wano Y., Hattori T., Matsuoka M., et al. IL-1 gene expression in adult T-cell leukemia. J Clin Invest. 80:1987;911-916.
93. Niitsu Y., Urushizaki Y., Koshida Y., et al. Expression of TGF-β gene in adult T cell leukemia. Blood. 17:1988;263-266.
94. Suva L.J., Winslow G.A., Wettenhall R.E.H., et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia cloning and expression . Science. 237:1987;893-896.
95. Watanabe T., Yamaguchi K., Takatsuki K., Osame M., Yoshida M. Constitutive expression of parathyroid hormone-related protein gene in human T-cell leukemia virus type 1 (HTLV-I) carriers and adult T cell leukemia that can be trans-activated by HTLV-I tax gene. J Exp Med. 172:1990;759-765.
96. Kinoshita T., Shimoyama M., Tobinai K., et al. Detection of mRNA for the tax,1/rex,1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T cell leukemia patients and viral carriers by using the PCR. Proc Natl Acad Sci USA. 86:1989;5620-5624.
97. Bilezikian J.P. Etiologies and therapy of hypercalcemia. Endocrinol Metab Clin North Am. 18:1989;389-414.
98. Minato K., Hanada S. An interim report of LSG4 treatment for advanced peripheral T-cell lymphoma. Int J Hematol. 54:1991;179.
99. Daenen S., Rojer R.A., Smit J.W., Halie M.R., Nieweg H.O. Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukemia. Br J Haematol. 58:1984;723-727.
100. Yamaguchi K., Yul L.S., Oda T., et al. Clinical consequences of 2′-deoxycoformycin treatment in patients with refractory adult T-cell leukemia. Leuk Res. 10:1986;989-993.
101. Waldmann T.A., White J.D., Goldman C.K., et al. The IL-2 receptor a target for monoclonal antibody treatment of human T-cell lymphotropic virus I-induced adult-T-cell leukemia . Blood. 82:1993;1701-1712.
102. Waldmann T.A. New approaches to the treatment of ATLL. Takatsuki K. Adult T-Cell Leukemia. 1994;222-238 Oxford University Press, Oxford.
103. Oguma S., Imamura Y., Kusumoto Y., et al. Accelerated declining tendency of human T-cell leukemia virus type I carrier rates among younger blood donors in Kumamoto, Japan. Cancer Res. 52:1992;2620-2623.
104. Ichimaru M., Ikeda S., Kinoshita K., Hino S., Tsagi Y. Mother-to-child transmission of HTLV-I. Cancer Detect Prev. 15:1991;172-181.
105. Miyoshi I., Yoshimoto S., Kubonishi I., et al. Infectious transmission of human T-cell leukemia virus to rabbits. Int J Cancer. 35:1985;81-85.
106. Suga T., Kameyama T., Kinoshita T., et al. Infection of rats with HTLV-1 a small-animal model for HTLV-I carriers . Int J Cancer. 49:1991;764-769.
107. Shida H., Tochikura T., Sato T., et al. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection. EMBO J. 6:1987;3379-3384.
108. Sawada T., Iwahara Y., Ishii K., Tagachi H., Hoshino H., Miyoshi I. Immunoglobulin prophylaxis against milkborne transmission of human T-cell leukemia virus type I in rabbits. J Infect Dis. 164:1991;1193-1196.
109. Gallo R.C. The first human retrovirus. Sci Am. 255:1986;88-98.
110. Gray G.S., White M., Bartman T., Mann D. Envelope gene sequence of HTLV-I isolate MT-2 and its comparison with other HTLV-I isolates. Virology. 177:1990;391-395.
111. Komarian F., Pelloquin F., de Thé G. In vivo genomic variability of HTLV-1 depends more upon geography than pathologies. J Virol. 65:1991;3770-3778.
112. Schulz T.F., Calabro M.-L., Hoad J.G., et al. HTLV-I envelope sequences from Brazil and Caribbean, and Romania. Clustering of sequences according to geographic origin and variability in an antigenic epitope. Virology. 184:1991;483-491.
113. Sherman M.P., Saksena N.K., Dube D.K., Yanagihara R., Poiesz B.J. Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea. J Virol. 66:1992;2556-2563.
114. Clapham P., Nagy K., Weiss R.A. Pseudotypes of human T-cell leukemia virus types I and II neutralization by patients' sera . Proc Natl Acad Sci USA. 81:1984;2886-2889.
115. Hoshino H., Clapham P.R., Weiss R.A., Miyoshi I., Yoshida M., Miwa M. Human T-cell leukemia virus type I. Pseudotype neutralization of Japanese and American isolates with human and rabbit sera. Int J Cancer. 36:1985;671-675.
116. Osterhaus A., Weljer K., Uytdehaug F., Jarrett O., Sundquist B., Morein B. Induction of protective immune response in cats by vaccination with feline leukemia virus ISCOM. J Immunol. 135:1985;591-596.
117. Marciani D.J., Kensii C.R., Beltz G.A., Hung C., Cronier J., Auber A. Genetically engineered subunit vaccine against feline leukemia virus protective immune response in cats . Vaccine. 9:1991;89-96.
118. Cotter S.M. Feline leukemia virus pathophysiology, prevention, and treatment . Cancer Invest. 10:1992;173-181.